Interní Med. 2018; 20(3): 136-138 | DOI: 10.36290/int.2018.055

Role of nephrologist in the treatment of cardiorenal syndrome

MUDr. Vladimíra Bednářová, CSc.
Klinika nefrologie VFN UK Praha

The kidneys play an important role in removing toxic substances from the body and in maintaining water and electrolyte balance.Various body systems are affected by complications arising from the acute or chronic renal insufficiency. Cardiorenal syndromeis defined as a combined disorder of the kidneys and of the cardiovascular system. It is classified into five subtypes primarilybased upon the organ that initiated the insult as well as the clinical presentation. Acute or chronic dysfunction in one organ mayinduce acute or chronic dysfunction of the other. The treatment of patients with cardiorenal syndrome is challenging. The treatingphysician should be either cardiologist or nephrologist, based on the cause of the syndrome. The joint strategy of the treatmentshould be applied and the goal is to achieve the clinical improvement of the patients' health status.

Keywords: acute kidney injury (AKI), chronic kidney disease (CKD), cardiorenal syndrome, cardiovascular complications, haemodialysis,
peritoneal dialysis

Received: August 14, 2019; Accepted: August 20, 2019; Prepublished online: August 20, 2019; Published: July 1, 2018  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Bednářová V. Role of nephrologist in the treatment of cardiorenal syndrome. Interní Med. 2018;20(3):136-138. doi: 10.36290/int.2018.055.
Download citation

References

  1. Drazner MH, Rame JE, Stevenson LW et al. Prognostic importance of elevated jugular venous pressure and a third heart sound in patients with heart failure. N Engl J Med 2001; 345: 574-581. Go to original source... Go to PubMed...
  2. Hebert K, Dias A, Delgado MC et al.: Epidemiology and survival of the five stages of chronic kidney disease in a systolic heart failure population. Eur J Heart Fail 2010; 12: 861-865. Go to original source... Go to PubMed...
  3. Ronco C.a ? Di Lullo L.bCardiorenal Syndrome in Western Countries: Epidemiology, Diagnosis and Management Approaches. Kidney Dis 2016; 2: 151-163. Go to original source... Go to PubMed...
  4. Di Lullo L Rivera R, Barbera V et al.: Sudden cardiac death and chronic kidney disease: from pathophysiology to treatment strategies. Int J Cardiol 2016; 217: 16-27
  5. Bock JS, Gottlieb SS. Cardiorenal syndrome: new perspectives. Circulation 2010; 121: 2592-2600. Go to original source... Go to PubMed...
  6. Ungar A, Fumagalli S, Marini M et al. Renal, but not systemic, hemodynamic effects of dopamine are influenced by the severity of congestive heart failure. Crit Care Med 2004; 32: 1125-1129. Go to original source... Go to PubMed...
  7. Ghafari A Urgent start peritoneal dialysis www.uptodate 2017.
  8. Costanzo MR: Ultrafiltration in the management of heart failure. Curr Opin Crit Care 2008; 14: 524-530. Go to original source... Go to PubMed...
  9. Ivarsen P, Povlsen JV. Can peritoneal dialysis be applied for inplanned initiation of chronic
  10. Couchoud CG, Beuscart JR, Aldigier J et al. Development risk stratification algorithm to improve patient-centered care with end-stage renal disease Kidney Int. 2015; 88: 1178-1186. Go to original source... Go to PubMed...
  11. Di Lullo L, Floccari F, Santoboni A et al: Progression of cardiac valve calcification and decline of renal function in CKD patients. J Nephrol 2013; 26: 739-744. Go to original source... Go to PubMed...
  12. K Siirila-Waris K, Lassus J, Melin J, et al: Characteristics, outcomes, and predictors of 1 year mortality in patients hospitalized for acute heart failure. Eur Heart J 2006; 27: 3011-3017. Go to original source... Go to PubMed...
  13. Yap SC, LeeHT Acute kidney injury and extrarenal organ dysfunction: new concepts and experimental evidence. Anesthsiology 2012: 116: 1139-1148 Go to original source... Go to PubMed...
  14. Kingma JG Jr, Vincent C, Rouleau JR et al. Influence of acute renal failure on coronary vasoregulation in dogs. J Am Soc Nephrol 2006: 17: 1316-1324 Go to original source... Go to PubMed...
  15. AG Schneider AG, Bellomo R, Bagshaw SM, et al. Choice of renal replacement therapy modality and dialysis dependence after acute kidney injury: a systematic review and meta-analysis. Intensive Care Med 2013; 39: 987-997. Go to original source... Go to PubMed...
  16. Go AS, Chertow GM, Fan D et al. Chronic kidney disease and the risks of death, cardiovascular events and hospitalization.N. J.Eg.Med 2004, 351, 1296-1305. Go to original source... Go to PubMed...
  17. Yeates K, Zhu N, Vonesh E, et al. Hemodialysis and peritoneal dialysis are associated with similar outcomes for end-stage renal disease treatment in Canada. Nephrol Dial Transplant 2012; 27: 3568. Go to original source... Go to PubMed...
  18. Weinhandl ED, Foley RN, Gilbertson DT et al. Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol. 2010; 21(3): 499. Epub 2010 Feb 4. Go to original source... Go to PubMed...
  19. Van de luithgaarden MW, Jager KJ, Segelmark M et al. Trends in dialysis modality choice and related patients survival in the ERA.EDTA Registry over 20-yer period. Nephrol Dial Transplant 2016, 31, 120-128. Go to original source... Go to PubMed...
  20. Wali RK, Wang GS, Gottlieb SS et al. Effect of kidney transplantation on left ventricular systolic dysfunction and congestive heart failure in patients with end-stage renal disease. J Am Coll Cardiol 2005; 45: 1051-1060. Go to original source... Go to PubMed...
  21. Reischig T. Preemptivní transplantace ledviny. In Viklický O. Predialýza.Maxdorf 2013.




Internal Medicine for Practice

Madam, Sir,
please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

I declare:

  1. that I have met the above instruction
  2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited


No

Yes

If your statement is not true, please be aware
that brings the risk of danger to their health or the health of others.